Literature DB >> 27438988

Clinicopathologic Characteristics of Solid Papillary Carcinoma of the Breast.

Benjamin Yongcheng Tan1, Aye Aye Thike, Ian O Ellis, Puay Hoon Tan.   

Abstract

Solid papillary carcinoma (SPC) of the breast is defined as a "distinctive form of papillary carcinoma characterized by closely apposed expansive, cellular nodules." This uncommon tumor frequently demonstrates neuroendocrine differentiation. SPCs are staged as in situ tumors, except those that exhibit jagged borders within desmoplastic stroma, or if accompanied by conventional invasive carcinoma, which is separately graded and staged. In this study, we review the immunomorphologic characteristics of SPCs diagnosed at our institution, with a view toward elucidating points of distinction from other mammary carcinomas that manifest neuroendocrine differentiation. A total of 250 cases of in situ and invasive carcinomas with immunohistochemically documented neuroendocrine differentiation, spanning 12 years, were retrieved from the records of the Department of Pathology, Singapore General Hospital. Morphologic review identified 108 (43.2%) cases of SPC (in situ and/or invasive) among this group of tumors. Tumors with SPC components were significantly associated with estrogen receptor, progesterone receptor, and chromogranin A expression, spindled tumor morphology, and older patient age (above median age). In addition, invasive carcinomas with SPC components were more likely to be of smaller size (≤20 mm), low grade (grade 1), and to occur in older patients (above median age), compared with cases of invasive carcinoma lacking an SPC component. In situ SPCs were significantly associated with mucin production and demonstrated improved disease-free survival over cases of conventional ductal carcinoma in situ with neuroendocrine differentiation. Presence of an SPC pattern is associated with favorable clinicopathologic characteristics, with in situ SPCs demonstrating improved disease-free survival, emphasizing the importance of accurately diagnosing this uncommon tumor.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27438988     DOI: 10.1097/PAS.0000000000000702

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.

Authors:  Gulisa Turashvili; Edi Brogi; Monica Morrow; Clifford Hudis; Maura Dickler; Larry Norton; Hannah Y Wen
Journal:  Breast Cancer Res Treat       Date:  2017-06-03       Impact factor: 4.872

Review 2.  Neuroendocrine Tumors of the Breast.

Authors:  Daniel W Visscher; Saba Yasir
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

Review 3.  Papillary neoplasms of the breast-reviewing the spectrum.

Authors:  Timothy Kwang Yong Tay; Puay Hoon Tan
Journal:  Mod Pathol       Date:  2021-01-18       Impact factor: 7.842

Review 4.  Renal clear cell carcinoma metastasis to the breast ten years after nephrectomy: a case report and literature review.

Authors:  Yanjun Xu; Rui Hou; Qijie Lu; Yifan Deng; Bin Hu
Journal:  Diagn Pathol       Date:  2017-11-02       Impact factor: 2.644

5.  Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid-papillary carcinoma.

Authors:  Matthias Christgen; Stephan Bartels; Jana Lisa van Luttikhuizen; Maximilian Schieck; Stefanie Pertschy; Sudip Kundu; Ulrich Lehmann; Bjoern Sander; Enrico Pelz; Florian Länger; Brigitte Schlegelberger; Doris Steinemann; Hans Kreipe
Journal:  J Pathol Clin Res       Date:  2017-07-19

6.  Solid Papillary Carcinoma of Breast: Clinicopathologic Comparison With Conventional Ductal Carcinoma of Breast.

Authors:  Atif A Hashmi; Syeda N Iftikhar; Rimsha Haider; Raviha Haider; Muhammad Irfan; Javaria Ali
Journal:  Cureus       Date:  2020-10-26

Review 7.  Breast carcinomas of low malignant potential.

Authors:  Stuart J Schnitt; Falko Fend; Thomas Decker
Journal:  Virchows Arch       Date:  2021-07-22       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.